Cardiology
All Content
Predicted risk of cardiac complications varies among risk calculators
How frequently is there concordance between three recommended risk calculators in categorizing a patient as low risk for major adverse cardiac...
Video
In PAD, dropping statins ups death risk 43%
PARIS – Statin adherence saves lives in peripheral arterial disease.
Video
DAPA-HF results transform dapagliflozin from antidiabetic to heart failure drug
News
Ticagrelor: Modest benefit, bigger bleed risk in diabetes plus stable CAD
Patients with prior PCI fared a bit better and may be a target population for long-term DAPT therapy.
News
POP AGE shakes up DAPT in elderly
PARIS – Clopidogrel hailed as P2Y12 inhibitor of choice in older patients with non-ST-elevation ACS.
News
FDA’s low-risk TAVR okay set to propel case volume
Clinical
Anticoagulant therapy for AFib in patients with end-stage renal disease
Apixaban may be safer than warfarin for patients who have ESRD and who plan for anticoagulation because of AFib.
Clinical
Treating children with Kawasaki disease and coronary enlargement
An important new study reveals a treatment protocol that decreases the rate of aneurysm enlargement.
News
Dapagliflozin meets primary endpoint in the DAPA-HF trial
AstraZeneca announces preliminary results in first heart failure trial in an SGLT2 inhibitor.
News
New biomarker model outmatches conventional risk factors for predicting mortality
Although the majority of these biomarkers have been associated with mortality before, this is the first study that shows their independent effect...